Government to fund vorasidenib for NHS patients

Summary

We call on the Government to fund vorasidenib for NHS patients with IDH-mutant low-grade glioma, notwithstanding the NICE decision on whether to so or not. People with this rare brain tumour are often young and trying to live full lives. Vorasidenib could give them more time before harsh treatments, more time with family, more time to hope. It feels wrong to deny that chance when a safe, effective therapy already exists.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.